Complete Clinical Response of BRAF-Mutated Cholangiocarcinoma to Vemurafenib, Panitumumab, and Irinotecan

J Gastrointest Cancer. 2016 Dec;47(4):502-505. doi: 10.1007/s12029-015-9792-2.

Sergey V Silkin¹, Sergey S Startsev¹, Marina E Krasnova¹, Grigory A Raskin², Natalia V Mitiushkina³, Aglaya G Iyevleva^{3

4}, Anna P Sokolenko^{3

4}, Evgeny N Imyanitov^{5

6

7

8}

¹ Regional Cancer Hospital, Yuzhno-Sakhalinsk, 693010, Russia.
² Russian Research Centre for Radiology and Surgical Technologies, St.-Petersburg, 197758, Russia.
³ Laboratory of Molecular Oncology, N.N. Petrov Institute of Oncology, Pesochny-2, 197758, St.-Petersburg, Russia.
⁴ Saint-Petersburg State Pediatric Medical University, St.-Petersburg, 194100, Russia.
⁵ Laboratory of Molecular Oncology, N.N. Petrov Institute of Oncology, Pesochny-2, 197758, St.-Petersburg, Russia. evgeny@imyanitov.spb.ru.
⁶ Saint-Petersburg State Pediatric Medical University, St.-Petersburg, 194100, Russia. evgeny@imyanitov.spb.ru.
⁷ Medical Faculty, Saint Petersburg State University, Saint-Petersburg, 199034, Russia. evgeny@imyanitov.spb.ru.
⁸ I.I. Mechnikov North-Western State Medical University, Saint-Petersburg, 191015, Russia. evgeny@imyanitov.spb.ru.

No abstract available

Publication types